Browsing Harvard Law School by Keyword "policy"
Now showing items 1-9 of 9
-
Ciprofloxacin and Compulsory Licensing of Pharmaceutical Patents
(2002)The recent threat of biological terrorism involving the Anthrax virus incited a debate about whether the United States government should use its powers under 28 USC §1498 to take a compulsory license on the ... -
Drug Reimportation: Prescription, Placebo, or Poison?
(2002)This paper examines drug reimportation as a means of reducing prescription drug prices paid by U.S. consumers. Specifically, this paper examines the provisions of the MEDS Act of 2000, which was passed by Congress right ... -
DTC Prescription Drug Advertising: The History and Impact of FDA Regulation
(2002)This paper traces the history of direct-to-consumer (DTC) advertising for prescription drugs in the United States, beginning with the enactment of the Federal Food, Drug, and Cosmetics Act in 1938 and continuing through ... -
IN CIPRO WE TRUST: BUT HOW DO WE FEEL ABOUT OUR DRUG PATENT LAWS? (2002 Third Year Paper)
(2002)In many ways, the terrorist attacks of September 11, 2001, crystallized national debate over drug patents both in Canada and the United States. This became clear when, at the height of the anthrax attacks in October, NBC's ... -
The Law of the Lab: Using Zerit to Inform Technology Transfer
(2002)The author takes a comprehensive look at the government’s policy of technology transfer, the process by which government-funded inventions are transferred to the private sector for commercialization. ... -
“Not in a Month Without an ‘R’ in its Name”: An Historical Overview of 20th Century Seafood Regulation With a Glimpse of the Challenges at the Beginning of the 21st
(2002)Part I of this article introduces the American seafood and shellfish industry and provides some background data on the composition of the market as well as consumption patterns in the United States. Consideration is given ... -
PRESCRIPTION DRUG PRICING: HOW MUCH IS TOO MUCH?
(2000)There are numerous proposals for controlling the increasing cost of prescription drugs. Some of these rely on more market-based approaches; some of them resemble traditional command and control. Many of the arguments that ... -
REIMPORTATION OF U.S. PHARMACEUTICALS: POLITICAL, ECONOMIC, AND LEGAL PERSPECTIVES
(2002)The high cost of prescription drugs in the United States is a problem that has engendered much political attention. One proposed solution to the prescription drug problem is to permit reimportation of U.S.-made drug products, ... -
Shocking the Conscience of the World: International Norms and the Access to AIDS Treatment in South Africa
(2003)This paper examines the emergence and institutionalization of a new international norm supporting greater access to lifesaving drugs in developing countries, particularly for HIV/AIDS drugs in South Africa. In order to ...